Altimmune, Inc. (ALT) Tops Q2 EPS by 4c
Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.